Axios @axios
The FDA will soon decide the fate of Biogen's experimental Alzheimer's drug. But there is one glaring issue — there is no conclusive evidence the drug effectively treats the crippling neurological disease. https://t.co/xuLMAOY0FL — PolitiTweet.org